Navigation Links
Photosynthesis: The last link in the chain
Date:1/4/2013

For almost 30 years, researchers have sought to identify a particular enzyme that is involved in regulating electron transport during photosynthesis. A team at Ludwig-Maximilians-Universitt (LMU) in Munich has now found the missing link, which turns out to be an old acquaintance.

Photosynthesis sustains life on Earth by providing energy-rich compounds and the molecular oxygen that higher organisms depend on. The process is powered by sunlight, which is captured by "biochemical solar cells" called photosystems that are found in plants, algae and certain types of bacteria. Plants have two photosystems, PSI and PSII. Each consists of a pigment-protein complex that uses solar energy to raise electrons to a higher energy level. These are then passed along a chain of electron acceptors, and the energy released is employed for synthesis of ATP, the "coinage" used for all energy transactions in cells.

Electron transport can proceed along several different routes. So-called linear electron transport requires the participation of both PSI and PSII, and delivers the electrons to a small molecule called NADP, forming NADPH. Cyclic electron flow on the other hand - which can take two alternative paths - involves only PSI, and is used solely for the production of ATP. Electrons that follow the major route are passed via an acceptor called plastoquinone to the cytochrome b6f complex and from there back to PSI, thus completing the cycle.

"The identity of the carrier that donates electrons to plastoquinone, and thus makes the process of cyclic electron flow possible, has long been a subject of controversy," says LMU biologist Professor Dario Leister, who, together with other members of his group, has now succeeded in identifying the crucial missing link in the process.

The crossroads that closes the circuit

Plants can switch between linear and cyclic modes of electron transport in order to maintain the appropriate balance between ATP and NADPH, both of which are required for synthesis of sugars from CO2. This implies that the allocation of electrons between the photosystems can be regulated. An electron transporter called ferredoxin, which receives electrons directly from PSI, acts as the junction that connects the two. "It was therefore proposed, more than 30 years ago, that a so-called ferredoxin-plastoquinone reductase (FQR) must exist, which ensures that electrons can be re-injected into the electron transport chain, and thus allows for cyclic electron transport," Leister explains, "but despite intensive searches, no such enzyme had been found."

In 2008, Leister's team identified a protein they called PGRL1, and showed that it was able to interact with PSI and with other factors known to participate in cyclic electron transport. In their latest study, they have been able to characterize the precise biochemical function of PGRL1. It turns out that the protein is the long-sought FQR that plays a central role in the regulation of cyclic electron flow. "In the long term, this finding may help us to improve photosynthetic performance by replacing or modifying specific components of the electron transport chain," Leister points out.

Pivotal regulators such as PGRL1 could possibly be tuned in a targeted fashion so as to enhance the efficiency of photosynthesis and thus increase yields in crop plants grown under controlled conditions. Furthermore, a complete understanding of the structure and regulation of the photosystems is a prerequisite for the development of methods that would allow one to optimize the process of photosynthesis for various applications such as raising crop yields, designing new types of solar cells or generating molecular hydrogen for use as an environmentally friendly energy source.


'/>"/>

Contact: Kathrin Bilgeri
kathrin.bilgeri@lmu.de
49-892-180-6938
Ludwig-Maximilians-Universitt Mnchen
Source:Eurekalert

Related biology news :

1. Oil and water: An icy interaction when oil chains are short, but steamy when chains are long
2. Chain reaction in the human immune system trapped in crystals
3. Pilot Results Move GHX Closer to Delivery of Healthcare Industrys First Implantable Device Supply Chain Solution
4. Stanford scientists document fragile land-sea ecological chain
5. Copper chains: Study reveals Earths deep-seated hold on copper
6. Study confirms oil from Deepwater Horizon disaster entered food chain in the Gulf of Mexico
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... 2, 2016   The Weather Company , an IBM ... an industry-first capability in which consumers will be able to ... ask questions via voice or text and receive relevant information ... Marketers have long sought an advertising solution that ... be personal, relevant and valuable; and can scale across millions ...
(Date:5/20/2016)... May 20, 2016  VoiceIt is excited to ... VoicePass. By working together, VoiceIt and ... VoiceIt and VoicePass take slightly different approaches to ... both security and usability. ... this new partnership. "This marketing and ...
(Date:5/3/2016)... VILNIUS, Lithuania , May 3, 2016 /PRNewswire/ ... today released the MegaMatcher Automated Biometric Identification ... deployment of large-scale multi-biometric projects. MegaMatcher ABIS can ... and accuracy using any combination of fingerprint, face ... of MegaMatcher SDK and MegaMatcher ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... Pleasant Prairie, WI (PRWEB) , ... June 23, ... ... sciences consultancy focused on quality, regulatory and technical consulting, provides a free ... webinar is presented on July 13, 2016 at 12pm CT at no charge. ...
Breaking Biology Technology: